Pharmacy & Therapeutics Committee

Next P & T Committee Meeting Date & Agenda

Date: December 14, 2021
Registration Deadline: November 30, 2021 by 5 pm EST
 

Register by email: [email protected]

Meeting: 8:00 AM
Location: To Be Determined

Agenda

Meeting Dates

  • September 21, 2021 - Cancelled
  • December 14, 2021

Meeting Minutes

All documents listed below are PDFs      

June 2021 (Draft)

April 2021

December 2020

Sept 2020

June 2020

Dec 2019

Sept 2019

June 2019

Apr 2019 

Dec 2018 

Sept 2018  

Jun 2018

Apr 2018

Dec 2017

Sept 2017

Jun 2017

Apr 2017

Dec 2016   

Sept 2016

Jun 2016 

Dec 2015

Aug 2015

Jun 2015

Apr 2015

Dec 2014 

Jun 2014

Apr 2014  

Dec 2013      

Aug 2013

Jun 2013

Apr 2013   

Dec 2012 

Sept 2012

Jun 2012

Apr 2012

Dec 2011

Sept 2011

Jun 2011

Apr 2011

Dec 2010 

Jun 2009

Apr 2009 

Dec 2008

Sept 2008

Jun 2008

Apr 2008

Dec 2007

Sept 2007

Jun 2007

Apr 2007

Dec 2006

 

 

Pharmacy & Therapeutics Committee Members

 

  • Tracey Taveria, PharmD, CDOE     
  • Richard Wagner, MD, DFAPA
  • Bill Quirk, RPH
  • Nickolai Morin, PharmD
  • Todd Brothers, PharmD, BCCCP, BCPS
  • Matthew Salisbury, MD
  • Gregory Allen, MD

 

Preferred Drug List (PDL)

The Preferred Drug List is a listing of therapeutic classes and associated drugs that are managed by the Medicaid Fee-for-Service Pharmacy and Therapeutic Committee.  It is not an all-inclusive list of covered medications in the Medicaid Fee-for-Service program.  If you have an NDC, please check the NDC lookup on the EOHHS healthcare portal to determine coverage.

Committee By Laws

Rhode Island Medical Assistance Pharmacy and Therapeutics Committee By-Laws  (June 2015).

Submission of Clinical Information

Clinical information relevant to products being reviewed at the upcoming P & T meeting can be submitted to Karen Mariano at [email protected]

Information should be limited to clinical information that would distinguish the product from others within its therapeutic class. For the June 8, 2021  meeting the deadline for submission is Tuesday, May 25, 2021. Any documents submitted late, by hard copy or for medications not under review at this P & T meeting, will not be reviewed by the committee.